decitabine – Talk Bio

Actionable Insights Powered by AI

Orum Therapeutics Appoints Chad May as Chief Scientific Officer

Orum Therapeutics; Chad May; CSO; Degrader-Antibody Conjugates; DAC; Targeted Protein Degradation